Koenig Sheldon L. — SEC Form 4 filings
SEC reporting owner CIK 1766524. 12 Form 4 filings on record with FilingPulse; latest filed 2026-07-13.
Transaction summary — filings shown
Covers all 12 filings on record, filed 2024-03-15 to 2026-07-13. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 8 legs across 8 filings — 226,355 shares, $605,316 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 10.
- Largest priced transaction: sale of 48,244 shares @ $3.67 ($177,200) in Esperion Therapeutics, Inc., filed 2025-12-18.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Esperion Therapeutics, Inc. (ESPR) | President and CEO, Director | 12 | — | 8 legs · 226,355 sh · $605,316 | 10 |
Form 4 filings — Koenig Sheldon L.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-13 | 4 | Esperion Therapeutics, Inc. (ESPR) | Disposition to issuer (D): 2,121,094 · Disposition to issuer (D): 642,000 (derivative) · Disposition to issuer (D): 753,000 (derivative) · Disposition to issuer (D): 647,460 (derivative) | EDGAR |
| 2026-06-18 | 4 | Esperion Therapeutics, Inc. (ESPR) | Sale (S): 53,588 @ $3.15 | EDGAR |
| 2026-03-18 | 4 | Esperion Therapeutics, Inc. (ESPR) | Sale (S): 25,578 @ $2.72 | EDGAR |
| 2026-03-16 | 4 | Esperion Therapeutics, Inc. (ESPR) | Grant/award (A): 723,760 @ $0 · Grant/award (A): 647,460 (derivative) @ $0 | EDGAR |
| 2025-12-18 | 4 | Esperion Therapeutics, Inc. (ESPR) | Sale (S): 48,244 @ $3.67 | EDGAR |
| 2025-09-18 | 4 | Esperion Therapeutics, Inc. (ESPR) | Sale (S): 28,427 @ $2.79 | EDGAR |
| 2025-06-18 | 4 | Esperion Therapeutics, Inc. (ESPR) | Sale (S): 30,474 @ $1.11 | EDGAR |
| 2025-03-19 | 4 | Esperion Therapeutics, Inc. (ESPR) | Sale (S): 13,047 @ $1.50 | EDGAR |
| 2025-03-17 | 4 | Esperion Therapeutics, Inc. (ESPR) | Grant/award (A): 840,000 @ $0 · Grant/award (A): 753,000 (derivative) @ $0 | EDGAR |
| 2024-12-18 | 4 | Esperion Therapeutics, Inc. (ESPR) | Sale (S): 12,447 @ $2.47 | EDGAR |
| 2024-09-18 | 4 | Esperion Therapeutics, Inc. (ESPR) | Sale (S): 14,550 @ $1.80 | EDGAR |
| 2024-03-15 | 4 | Esperion Therapeutics, Inc. (ESPR) | Grant/award (A): 454,000 @ $0 · Grant/award (A): 642,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1766524 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →